BSEAGM/EGM1d ago · 21 Jul 2026, 02:50 pm

35th Annual General Meeting is scheduled on Friday, August 14, 2026 at 12:15 HRS IST.

Strides Pharma Science Ltd · 532531

✦ AI SummaryResults

Strides Pharma Science Ltd is scheduling its 35th Annual General Meeting (AGM) on August 14, 2026, through video conference or other audio-visual means. The meeting will consider the audited financial statements for FY2025-26 and other business.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Strides Pharma Science Ltd - 532531 - Notice Of 35Th Annual General Meeting

Attachments (1)

📄

eaa386b5-3087-4fb7-acc1-e981055eb35c.pdf

pdf

Download →
View document text
July 21, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 532531 Scrip Code: STAR Dear Madam/ Sir, Sub: Intimation under Regulation 34 of the SEBI Listing Regulations Reg: Notice of 35th Annual General Meeting and Annual Report for FY2025-26 This is to inform you that 35th Annual General Meeting (AGM) of the Company is scheduled to be held on Friday, August 14, 2026 at 12:15 hrs IST through Video Conference/ Other Audio-Visual Means (VC/ OAVM). AGM is being convened in compliance with the applicable provisions of the Companies Act, 2013 and Rules made thereunder ("Act"), the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") and applicable circulars/ notifications issued by the Ministry of Corporate Affairs ("MCA") and SEBI from time to time. In compliance with the aforesaid MCA and SEBI Circulars, please find enclosed a copy of Notice of 35th AGM along with Annual Report for FY 2025-26 (including Business Responsibility and Sustainability Report) being sent through electronic mode to those Shareholders whose email addresses are registered with the Company/ Depositories/ Registrar and Transfer Agent (RTA). Further, please find enclosed a copy of the communication being sent to those shareholders whose email addresses are not registered with the Company/ Depositories/ RTA, providing the web link and the exact path through which the Annual Report can be accessed. Physical copy of Annual Report for FY 2025-26 shall be sent to those Shareholders who request for the same. Key event dates relating to 35th AGM are provided below, for ready reference: Particulars Details Cut-off date for eligibility for e-voting Thursday, August 7, 2026 Link for remote e-voting https://evoting.kfintech.com/ Time period for e-voting Starts from Monday, August 10, 2026 at 09:00 hrs IST Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com Ends on Thursday, August 13, 2026 at 17:00 hrs Record Date for Dividend Friday, July 31, 2026 Last date for publishing results of On or before Tuesday, August 18, 2026 e-voting This is for your information and records. Thanks & Regards, For Strides Pharma Science Limited, Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No.: A30515 Encl. As above Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com STRIDES PHARMA SCIENCE LIMITED CIN: L24230MH1990PLC057062 Regd. Office: Cyber One, Unit No. 902, Plot No - 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, Maharashtra, India Tel No: +91 22 2789 2924/ 2789 3199 Corp. Office: ‘Strides House’, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, Karnataka, India. Tel No.: +91 80 6784 0000/ 6784 0290 Website: www.strides.com; Email: investors@strides.com Dear Shareholders, Sub: Invitation to attend Thirty-fifth Annual General Meeting Annual General Meeting of the Company to be held on Friday, August 14, 2026. You are cordially invited to attend Thirty-fifth Annual General Meeting (AGM) of the Company scheduled to be held on Friday, August 14, 2026 at 12:15 hrs IST through Video Conferencing (VC)/ Other Audio- Visual Means (OAVM). Notice convening the AGM is enclosed herewith. To enable ease of participation, please find below key details regarding the meeting: # Particulars Details 1) Link for live webcast of the AGM https://emeetings.kfintech.com/ and for participation through VC Shareholders may attend the AGM through VC by accessing the above link or by using the remote e-voting credentials. Please refer the instructions of this Notice for further information. 2) Link for remote e-voting https://evoting.kfintech.com/ 3) Cut-off date for e-voting Friday, August 7, 2026 4) Time period for e-voting Starts on Monday, August 10, 2026 at 09:00 hrs IST Ends on Thursday, August 13, 2026 at 17:00 hrs IST 5) Last date for publishing results of On or before Tuesday, August 18, 2026 e-voting 6) Contact details of Registrar and Mr. Sashidhar Mannava, Vice President-Corporate Registry/ Share Transfer Agent (RTA) Mr. Mohan Kumar A, Senior Manager 7) Helpline number for VC KFin Technologies Limited participation and (formerly known as KFin Technologies Private Limited) e-voting Unit: Strides Pharma Science Limited E-mail:einward.ris@kfintech.com; evoting@kfintech.com Toll Free No.: 1800 309 4001 Page 1 of 38 8) Scrutinizer Details Mr. Gigi Joseph K J, Practicing Company Secretary (ICSI Membership No. F6483 and CP:5576) of M/s. Joseph and Chacko LLP, Company Secretaries, Bengaluru Email: gigi@jandc.in 9) Strides contact details Email: investors@strides.com Tel No.: +91 80 6784 0732/ 0734 Best Regards, For Strides Pharma Science Limited Sd/- Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515 Page 2 of 38 AGM NOTICE NOTICE is hereby given that Thirty-fifth Annual General Meeting (AGM) of the Shareholders of Strides Pharma Science Limited (Company) will be held on Friday, August 14, 2026, at 12:15 hrs IST through Video Conference (VC)/ Other Audio-Visual Means (OAVM) to transact the following businesses: ORDINARY BUSINESS Item No.1: To receive, consider and adopt the Audited Financial Statements of the Company (including Consolidated Financial Statements) for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and Auditors thereon. To consider and if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED that Audited Standalone & Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and Auditors thereon, as circulated to the members, be and are hereby received, considered and adopted.” Item No.2: Declaration of Final Dividend for the Financial Year ended March 31, 2026. To declare a Final Dividend of Rs. 5 per equity share of face value Rs. 10/- each for the Financial Year ended March 31, 2026. To consider and if thought fit, to pass the following resolution as an ordinary resolution: “RESOLVED that pursuant to recommendation of Board of Directors of the Company, approval of shareholders of the Company be and is hereby accorded for the payment of a final dividend of Rs. 5/- per equity share of ₹ 10/- each, for the financial year ended March 31, 2026, to all the Shareholders whose names appear in the Register of Members and the records of the Depositories as on July 31, 2026 (“Record Date”) RESOLVED FURTHER that any Director or Company Secretary of the Company be and are hereby severally authorised to do all such acts, deeds, matters and things and sign and file all such papers, documents, forms and writings as may be necessary and incidental to give effect to the aforesaid resolution”. Item No.3: Re-appointment of Retiring Director. Pursuant to Section 152 of the Companies Act, 2013, Mr. Arun Kumar (DIN: 00084845) retires by rotation and being eligible, offers himself for re-appointment as Director of the Company. Arun is the Founder, Non-Executive Director & Chairperson of the Company. Relevant details of Mr. Arun Kumar pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Secretarial Standard on General Meetings issued by the Institute of Company Secretaries of India is enclosed as an Annexure 1 to this Notic [Showing first 8,000 characters — download PDF for full document]